Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000030458 | SCV000153933 | benign | Hereditary pancreatitis | 2024-01-31 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001723591 | SCV000605245 | benign | not provided | 2023-10-26 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000030458 | SCV000782315 | likely benign | Hereditary pancreatitis | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000030458 | SCV001136990 | likely benign | Hereditary pancreatitis | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000030458 | SCV001172990 | benign | Hereditary pancreatitis | 2016-02-15 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV000030458 | SCV001316925 | benign | Hereditary pancreatitis | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Institute of Human Genetics, |
RCV001262267 | SCV001440072 | likely benign | Tropical pancreatitis | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001723591 | SCV002005559 | likely benign | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 17568390, 22427236, 17525091, 27253233, 28994706, 15764155, 12360464, 10982753, 20977904, 26100556, 11265669, 12822871, 12634855, 23951356, 10835640, 10691414) |
Sema4, |
RCV000030458 | SCV002535380 | benign | Hereditary pancreatitis | 2020-02-24 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000248152 | SCV004025089 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001723591 | SCV004157286 | likely benign | not provided | 2022-04-01 | criteria provided, single submitter | clinical testing | SPINK1: BP4, BS1 |
Breakthrough Genomics, |
RCV001723591 | SCV005228117 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030458 | SCV000053128 | benign | Hereditary pancreatitis | 2011-08-11 | no assertion criteria provided | clinical testing | |
Gene |
RCV000030458 | SCV000153739 | not provided | Hereditary pancreatitis | no assertion provided | literature only | ||
Prevention |
RCV003891447 | SCV000309393 | benign | SPINK1-related disorder | 2020-11-19 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001723591 | SCV001958041 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001723591 | SCV001972550 | likely benign | not provided | no assertion criteria provided | clinical testing |